Back g round/Aims Facial nerve palsy can be a sight-threatening complication. We have Eyelid surgery seems to be the mainstay of treatment, for both function and cosmesis, with many patients requiring a combination of procedures.
Results
Of all the patients undergoing primary acoustic neuroma excision during the above period, 48 sustained a chronic post-operative facial palsy (group A), and 8 sustained a temporary palsy (group B). The first 5 had been followed up prospectively by ourselves to ensure adequate understanding and working of the protocol by the neurosurgical staff. the diplopia resolved completely (all had a mild superior or lateral rectus muscle underaction) and 4 were treated with either a Fresnel prism or ocular occlusion (all had a large or moderate superior rectus muscle underaction).
None required squint surgery.
Twenty-four patients (50%) required a total of 64 eyelid operations in one form or another, and the number and types of single procedures performed during the follow-up period are shown in Table 1 . All these patients had severe palsies, except for 1 with a moderate palsy who required one procedure only. In only 7 patients (29.2%) was a single procedure sufficient to prevent corneal exposure or improve patients' symptoms, with 
Discussion
The eyelids provide a physical barrier to trauma and drying, and they inhibit adherence of organisms to the ocular surface. Tears provide mechanical lubrication to wash away organisms, and they also contain 
months have elapsed since acoustic neuroma surgery.
BTXA injection does provide a good means of providing corneal coverage by paralysing the levator palpebrae muscle and so inducing a ptosis, especially when a patient is unable to undergo eyelid surgery (e.g. whilst in intensive care). BXTA is minimally invasive and can be performed without any anaesthesia at all. It allows for easy ocular examination and instillation of any topical treatment required, whilst at the same time it does not cause any eyelid scarring. A 45% rate of complications following BTXA in the form of rectus muscle underaction and resulting diplopia (although half resolve quickly) is cause for concern, but is less than the rate when BTXA is given along the roof of the orbit.8 Although there were no persistent cases of diplopia in the original series, squint surgery has been required in subsequent patients receiving BTXA along the roof of the orbit. 9 We feel that our lower rate of diplopia occurrence may be due to the lower site of injection, i.e. through the skin crease rather than below the superior orbital margin, and this may allow less spread of toxin to the adjacent recti. We are at present investigating alternative injection methods and sites for BTXA in order to reduce the associated complications.
Although the advent of BTXA has meant that we have trigeminal neuropathy (16 of 56 of our patients), the eye is at even greater risk, and in such circumstances we do aim for an overcorrection so that the eyelid is ptotic.
Passive reanimation of the upper eyelid can be performed with gold weight loading, which allows gravity-aided passive eyelid closure and blink whilst erect. As it is gravity dependent, it may not cause closure when supine, although a better mass effect is obtained by placing the weight inferiorly. We have tended not to use these methods as these There are many procedures that may be undertaken -a fact which indicates that no one procedure is the ideal.
Indeed many patients seem to require a combination of procedures, which is borne out by other authors also.16
